Skip to main content
Log in

Risks related to lack of standardization of tests to detect in vitro metronidazole resistance inHelicobacter pylori

  • Articles
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

The correlation between metronidazole MIC readings obtained in vitro on two different media for two different inoculum dilutions was studied after two, three, and five days of incubation using 20 clinical isolates ofHelicobacter pylori. The PDM epsilometer (E test) was used. After two days of incubation, log MIC values on chocolate PDM and Vestfold charcoal medium, a new charcoal medium, showed good correlation. Charcoal media can thus be used for metronidazole sensitivity tests. In terms of double-dilution gradients, prolongation of incubation time from two to three days and change of inoculum dilution from 0.5 to 4 McFarland had little impact when studied separately. However, the combined effect of the two variables was marked. The matching of a sparse inoculum incubated for two days against a heavy inoculum incubated for three days resulted in readings which, for 30% of the pairs, differed by two double-dilution gradients or more. On the other hand, the separate influence of both variables was found to affect the correlation coefficients significantly. Five days of incubation was associated with a poor correlation when the variables were studied both separately and combined. Thus, the real influence of separate variables on MIC readings was not exposed in a scale of double-dilution gradients because the intervals were too large. For this reason, scales without thresholds are recommended.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Glupczynski Y: Results of a multicenter European survey in 1991 of metronidazole resistance inHelicobacter pylori. European Journal of Clinical Microbiology & Infectious Diseases 1992, 11: 777–781.

    Google Scholar 

  2. Glupczynski Y, Burette A: Drug therapy forHelicobacter pylori infection: problems and pitfalls. American Journal of Gastroenterology 1990, 85: 1545–1551.

    PubMed  Google Scholar 

  3. Talley NJ, Noack KB: The worldwide prevalence ofHelicobacter pylori: asymptomatic infection and clinical states associated with infection in adults. In: Goodwin CS (ed):Helicobacter pylori: biology and clinical practice. CRC Press, Boca Raton, FL, 1993, p. 63–83.

    Google Scholar 

  4. Becx MCJM, Janssen AJHM, Clasener HAL, de Koning RW: Metronidazole-resistantHelicobacter pylori. Lancet 1990, 335: 539–540.

    Google Scholar 

  5. Glupczynski Y, Burette A, de Koster E, Nyst JF, Deltenre M, Cadranel S, Bordeaux L, de Vos D: Metronidazole resistance inHelicobacter pylori. Lancet 1990, 335: 976–977.

    Google Scholar 

  6. Noach LA, Langenberg WL, Bertola MA, Dankert J, Tytgat GNJ: Impact of metronidazole resistance on the eradication ofHelicobacter pylori. Scandinavian Journal of Infectious Diseases 1994, 26: 321–327.

    PubMed  Google Scholar 

  7. Rautelin H, Säppäla K, Renkonen OV, Vainio U, Kosunen TU: Role of metronidazole resistance in therapy ofHelicobacter pylori infections. Antimicrobial Agents and Chemotherapy 1992, 36: 163–166.

    PubMed  Google Scholar 

  8. Bell GP, Powell K, Burridge SM, Pallecoras A, Jones PH, Gant PW, Harrison G, Trowell JE: Experience with “triple” anti-Helicobacter pylori eradication therapy: side effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance. Alimentary Pharmacology and Therapeutics 1992, 6: 427–435.

    PubMed  Google Scholar 

  9. Goodwin CS: The susceptibility ofHelicobacter pylori to antibiotics. In: Goodwin CS (ed):Helicobacter pylori: biology and clinical practice. CRC Press, Boca Raton, FL, 1993, p. 343–349.

    Google Scholar 

  10. Berstad A, Berstad K, Hatlebakk JG, Wilhelmsen I, Nysæter G, Bang CJ, Hausken T, Nesje LB, Hjartholm AS: Ti dagers trippelkur forHelicobacter pylori-inieksjon og magesår. Tidsskrift for Den Norske Laegeforening 1994, 114: 2477–2479.

    PubMed  Google Scholar 

  11. Aursnes I: Norsk oppdateringskonferanse om behandling avHelicobacter pylori ved ulcus pepticum. Tidsskrift for Den Norske Laegeforening 1994, 114: 2495–2497.

    PubMed  Google Scholar 

  12. Knapp CC, Ludwig MD, Washington JA: In vitro activity of metronidazole againstHelicobacter pylori as determined by agar dilution and agar diffusion. Antimicrobial Agents and Chemotherapy 1991, 35: 1230–1231.

    PubMed  Google Scholar 

  13. Cederbrant G, Kahlmeter G, Ljungh Å: The E test for antimicrobial susceptibility testing ofHelicobacter pylori. Journal of Antimicrobial Chemotherapy 1993, 31: 65–71.

    Google Scholar 

  14. Glupczynski Y, Labbé M, Hansen W, Crokaert F, Yourassowsky E: Evaluation of the E test for quantitative antimicrobial susceptibility testing forHelicobacter pylori. Journal of Clinical Microbiology 1991, 29: 2072–2075.

    PubMed  Google Scholar 

  15. Henriksen TH, Brorson Ö, Schöyen R, Thoresen T, Setegn D, Madebo T: Rapid growth ofHelicobacter pylori. European Journal of Clinical Microbiology & Infectious Diseases 1995, 14: 1008–1011.

    Google Scholar 

  16. Westblom TU, Madan E, Midkiff BR: Egg yolk emulsion agar, a new medium for the cultivation ofHelicobacter pylori. Journal of Clinical Microbiology 1991, 29: 819–821.

    PubMed  Google Scholar 

  17. Cederbrant G, Kahlmeter G, Ljungh Å: Proposed mechanism for metronidazole resistance inHelicobacter pylori. Journal of Antimicrobial Chemotherapy 1992, 29: 115–120.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Henriksen, T.H., Brorson, Ö., Schöyen, R. et al. Risks related to lack of standardization of tests to detect in vitro metronidazole resistance inHelicobacter pylori . Eur. J. Clin. Microbiol. Infect. Dis. 15, 484–488 (1996). https://doi.org/10.1007/BF01691316

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01691316

Keywords

Navigation